X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ABBOTT INDIA - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ABBOTT INDIA IPCA LABS/
ABBOTT INDIA
 
P/E (TTM) x 37.8 35.7 105.9% View Chart
P/BV x 3.5 10.3 33.7% View Chart
Dividend Yield % 0.1 0.6 24.9%  

Financials

 IPCA LABS   ABBOTT INDIA
EQUITY SHARE DATA
    IPCA LABS
Mar-17
ABBOTT INDIA
Mar-17
IPCA LABS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs6435,190 12.4%   
Low Rs5034,351 11.6%   
Sales per share (Unadj.) Rs254.41,382.9 18.4%  
Earnings per share (Unadj.) Rs16.1130.2 12.3%  
Cash flow per share (Unadj.) Rs29.8137.9 21.6%  
Dividends per share (Unadj.) Rs1.0040.00 2.5%  
Dividend yield (eoy) %0.20.8 20.8%  
Book value per share (Unadj.) Rs194.6652.7 29.8%  
Shares outstanding (eoy) m126.2021.25 593.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.33.4 65.3%   
Avg P/E ratio x35.736.6 97.3%  
P/CF ratio (eoy) x19.234.6 55.6%  
Price / Book Value ratio x2.97.3 40.3%  
Dividend payout %6.230.7 20.3%   
Avg Mkt Cap Rs m72,300101,373 71.3%   
No. of employees `00013.33.1 431.5%   
Total wages/salary Rs m6,9603,453 201.6%   
Avg. sales/employee Rs Th2,413.59,531.9 25.3%   
Avg. wages/employee Rs Th523.21,119.9 46.7%   
Avg. net profit/employee Rs Th152.4897.3 17.0%   
INCOME DATA
Net Sales Rs m32,10629,387 109.3%  
Other income Rs m226576 39.2%   
Total revenues Rs m32,33229,963 107.9%   
Gross profit Rs m4,4483,973 111.9%  
Depreciation Rs m1,730164 1,052.6%   
Interest Rs m24120 1,180.4%   
Profit before tax Rs m2,7034,365 61.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6751,598 42.2%   
Profit after tax Rs m2,0282,767 73.3%  
Gross profit margin %13.913.5 102.5%  
Effective tax rate %25.036.6 68.2%   
Net profit margin %6.39.4 67.1%  
BALANCE SHEET DATA
Current assets Rs m17,34018,906 91.7%   
Current liabilities Rs m9,5596,297 151.8%   
Net working cap to sales %24.242.9 56.5%  
Current ratio x1.83.0 60.4%  
Inventory Days Days10062 161.3%  
Debtors Days Days5722 262.8%  
Net fixed assets Rs m20,7791,159 1,793.2%   
Share capital Rs m252213 118.8%   
"Free" reserves Rs m24,49913,657 179.4%   
Net worth Rs m24,55313,869 177.0%   
Long term debt Rs m3,5170-   
Total assets Rs m39,59520,638 191.9%  
Interest coverage x12.2215.0 5.7%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.81.4 56.9%   
Return on assets %5.713.5 42.4%  
Return on equity %8.319.9 41.4%  
Return on capital %10.531.6 33.2%  
Exports to sales %48.60-   
Imports to sales %14.20-   
Exports (fob) Rs m15,617NA-   
Imports (cif) Rs m4,571NA-   
Fx inflow Rs m15,6170-   
Fx outflow Rs m5,8280-   
Net fx Rs m9,7900-   
CASH FLOW
From Operations Rs m2,7643,072 90.0%  
From Investments Rs m-1,432-1,554 92.1%  
From Financial Activity Rs m-1,591-898 177.3%  
Net Cashflow Rs m-259621 -41.7%  

Share Holding

Indian Promoters % 45.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 11.4 7.9 144.3%  
FIIs % 25.3 0.1 25,300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 17.1 101.8%  
Shareholders   36,892 18,270 201.9%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   NOVARTIS  ASTRAZENECA PHARMA  DISHMAN PHARMA  CIPLA  JUBILANT LIFE SCIENCES  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Extend Gains; Energy & PSU Stocks Rally(12:30 pm)

Stock markets in India continue to trade higher taking cues from their key Asian counterparts. Sectoral indices are trading in green with stocks in the oil & gas sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


May 28, 2018 03:15 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS